Louisiana 2014 2014 Regular Session

Louisiana Senate Bill SB556 Introduced / Bill

                    SLS 14RS-521	ORIGINAL
Page 1 of 2
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.
Regular Session, 2014
SENATE BILL NO. 556
BY SENATOR JOHNS 
CONTROL DANGER SUBSTANCE.  Amends frequency of reporting prescription
dispensing of certain substances to the state prescription monitoring board. (8/1/14)
AN ACT1
To amend and reenact R.S. 40:1006(B), relative to the reporting of prescription monitoring2
information; to provide for reporting at a frequency to be determined by the3
Louisiana Board of Pharmacy; and to provide for related matters.4
Be it enacted by the Legislature of Louisiana:5
Section 1.  R.S. 40:1006(B) is hereby amended and reenacted to read as follows: 6
ยง1006. Reporting of prescription monitoring information7
*          *          *8
B. Each dispenser shall submit the required information in accordance with9
transmission methods and frequency established by the board. Each eligible10
prescription transaction shall be reported as soon as possible but in no event more11
than seven days after the date of dispensing.12
*          *          *13
The original instrument and the following digest, which constitutes no part
of the legislative instrument, were prepared by Mary Dozier O'Brien.
DIGEST
Johns (SB 556) SB NO. 556
SLS 14RS-521	ORIGINAL
Page 2 of 2
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.
Present law provides that information on the prescribing of certain controlled dangerous
substances shall be reported no longer than seven days after the date of dispensing.
Proposed law deletes the provision regarding seven days and leaves in tact the provision that
such reporting shall be at the frequency determined by the La. Board of Pharmacy.
Effective August 1, 2014.
(Amends R.S. 40:1006(B))